Two thirds (66 percent) of people with dementia live in low - and middle - income countries, where less than 10 percent of population - based research has been conducted. (scientificamerican.com)
Cases like this «raise important questions about the safety of this and other commonly used agents in patients with dementia,» note the authors. (uchospitals.edu)
Other research has shown that cognitive symptoms progress more rapidly in people living with dementia when they suffer inflammatory episodes, like chest and urine infections. (sciencemediacentre.org)